Chemical atherectomy. A novel approach to restenosis.
Naftilan
A J
AJ
D036002:ADP Ribose Transferases; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D001161:Arteriosclerosis / Q000188:drug therapy*; D001427:Bacterial Toxins; D002470:Cell Survival; D003327:Coronary Disease / Q000628:therapy; D005098:Exotoxins / Q000235:genetics; D005821:Genetic Techniques; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000378:metabolism; D012008:Recurrence; D016211:Transforming Growth Factor alpha / Q000235:genetics; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
D036002:ADP Ribose Transferases; D000806:Angiotensin-Converting Enzyme Inhibitors; D001427:Bacterial Toxins; D005098:Exotoxins; D010982:Platelet-Derived Growth Factor; D016211:Transforming Growth Factor alpha; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A